FDA allows pharmacies to repackage propofol for hospital patients

The Food and Drug Administration this week issued guidance allowing pharmacies and outsourcing facilities to repackage, under certain conditions and during the public health emergency, FDA-approved propofol drug products for hospitals having difficulty obtaining adequate supplies in the sizes they use to support or treat patients with COVID-19.

Also this week, FDA issued an emergency use authorization for IntelliVue Patient Monitors to remotely monitor hospital patients and reduce the risk of exposing health care providers to COVID-19.